Phase III clinical trial - Appareil pulmonaire

CheckMate 816 (CA209-816)
Appareil pulmonaire
Essai clinique fermé
Public cible
Randomized, OpenLabel, Phase 3 Trial of Nivolumab and Ipilimumab Versus Platinum Doublet Chemotherapy in Early Stage NSCLC.
Description de l'essai
The purpose of this study is to determine the safety and effectiveness of nivolumab and ipilimumab compared to chemotherapy in the treatment of Early Stage Non-Small Cell Lung Cancer